These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33736919)

  • 21. Australian Meningococcal Surveillance Programme annual report, 2014.
    Lahra MM; Enriquez RP
    Commun Dis Intell Q Rep; 2016 Jun; 40(2):E221-8. PubMed ID: 27522133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B in a nursery school, Wallonia, Belgium, 2018.
    Jacquinet S; Mattheus W; Quoilin S; Wyndham-Thomas C; Martin C; Van der Linden D; Mulder A; Frère J; Schirvel C
    Euro Surveill; 2022 Mar; 27(9):. PubMed ID: 35241214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy.
    Pezzotti P; Miglietta A; Neri A; Fazio C; Vacca P; Voller F; Rezza G; Stefanelli P
    Vaccine; 2018 Jul; 36(29):4222-4227. PubMed ID: 29895504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive meningococcal disease: Timing and cause of death in England, 2008-2015.
    Beebeejaun K; Parikh SR; Campbell H; Gray S; Borrow R; Ramsay ME; Ladhani SN
    J Infect; 2020 Mar; 80(3):286-290. PubMed ID: 31904388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic characterization of invasive meningococcal X isolates from Brazil, 1992-2022.
    Cassiolato AP; Camargo CH; Piccoli Cecconi MC; Christakis S; Gonçalves CR; Rodrigues Campos K; Takenori Higa F; Andrade Pereira G; de Moraes C; Silva de Lemos AP
    Int Microbiol; 2023 Aug; 26(3):611-618. PubMed ID: 36626096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Australian Meningococcal Surveillance Programme annual report, 2013.
    Lahra MM; Enriquez RP
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E301-8. PubMed ID: 25631592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations].
    Křížová P; Vacková Z; Musílek M; Kozáková J
    Epidemiol Mikrobiol Imunol; 2013 Dec; 62(4):138-47. PubMed ID: 24467175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of
    Xu J; Chen Y; Yue M; Yu J; Han F; Xu L; Shao Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2071077. PubMed ID: 35687866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimated strain coverage of serogroup B meningococcal vaccines: A retrospective study for disease and carrier strains in Greece (2010-2017).
    Tzanakaki G; Xirogianni A; Tsitsika A; Clark SA; Kesanopoulos K; Bratcher HB; Papandreou A; Rodrigues CMC; Maiden MCJ; Borrow R; Tsolia M
    Vaccine; 2021 Mar; 39(11):1621-1630. PubMed ID: 33597116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive Meningococcal Disease in Africa's Meningitis Belt: More Than Just Meningitis?
    Reese HE; Ronveaux O; Mwenda JM; Bita A; Cohen AL; Novak RT; Fox LM; Soeters HM
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S263-S265. PubMed ID: 31671435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The burden of invasive meningococcal disease in the Netherlands, 2011-2020.
    Middeldorp M; Steens A; Lagerweij G; van Sorge NM; Freudenburg-de Graaf W; A M Sanders E; de Melker HE; Knol MJ
    Vaccine; 2023 Apr; 41(16):2664-2670. PubMed ID: 36933982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactive vaccination as control strategy for an outbreak of invasive meningococcal disease caused by
    Fazio C; Daprai L; Neri A; Tirani M; Vacca P; Arghittu M; Ambrosio L; Cereda D; Gramegna M; Palmieri A; Carannante A; Bertoli MR; Crottogini L; Gennati G; Quinz E; Trezzi L; Ciammaruconi A; Fillo S; Fortunato A; Rezza G; Lista F; Stefanelli P
    Euro Surveill; 2022 Jun; 27(24):. PubMed ID: 35713021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of invasive Neisseria meningitidis isolates recovered from children in Turkey during a period of increased serogroup B disease, 2013-2017.
    Ceyhan M; Ozsurekci Y; Lucidarme J; Borrow R;
    Vaccine; 2020 Apr; 38(19):3545-3552. PubMed ID: 32199701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study.
    Knol MJ; Hahné SJM; Lucidarme J; Campbell H; de Melker HE; Gray SJ; Borrow R; Ladhani SN; Ramsay ME; van der Ende A
    Lancet Public Health; 2017 Oct; 2(10):e473-e482. PubMed ID: 29253430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the effect of targeted strategies as control tools for hypervirulent meningococcal C outbreaks: a case study from Tuscany, Italy, 2015 to 2016.
    Guzzetta G; Ajelli M; Miglietta A; Fazio C; Neri A; Merler S; Rezza G; Stefanelli P
    Euro Surveill; 2023 May; 28(19):. PubMed ID: 37166763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical manifestations of invasive meningococcal disease in Victoria with the emergence of serogroup W and serogroup Y Neisseria meningitidis.
    Birrell MT; Strachan J; Holmes NE; Stevens K; Howden BP; Franklin LJ; Ivan M; Kwong JC
    Intern Med J; 2021 Mar; 51(3):390-397. PubMed ID: 32043702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct evolutionary patterns of Neisseria meningitidis serogroup B disease outbreaks at two universities in the USA.
    Hao L; Holden MTG; Wang X; Andrew L; Wellnitz S; Hu F; Whaley M; Sammons S; Knipe K; Frace M; McNamara LA; Liberator P; Anderson AS
    Microb Genom; 2018 Apr; 4(4):. PubMed ID: 29616896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
    Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA;
    Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: The first case in Japan.
    Kawasaki Y; Matsubara K; Takahashi H; Morita M; Ohnishi M; Hori M; Isome K; Iwata A; Nigami H; Ikemachi M; Yamamoto G; Ohkusu K
    J Infect Chemother; 2018 Apr; 24(4):305-308. PubMed ID: 29233459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Australian Meningococcal Surveillance Programme annual report, 2018.
    Lahra MM; Enriquez RP; Hogan TP;
    Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32178605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.